AAIS
DXCM icon

ABN AMRO Investment Solutions’s DexCom DXCM Stock Holding History

ABN AMRO Investment Solutions’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.92M Buy
43,326
+3,475
+9% +$232K 0.03% 339
2026
Q1 		$2.5M Buy
39,851
+433
+1% +$30.2K 0.03% 308
2025
Q4 		$2.62M Buy
39,418
+4,319
+12% +$279K 0.04% 279
2025
Q3 		$2.36M Buy
35,099
+30,649
+689% +$2.43M 0.05% 238
2025
Q2 		$388K Buy
4,450
+441
+11% +$34.6K 0.01% 365
2025
Q1 		$274K Sell
4,009
-4,053
-50% -$331K 0.01% 391
2024
Q4 		$627K Buy
8,062
+2,346
+41% +$174K 0.01% 332
2024
Q3 		$383K Sell
5,716
-29,018
-84% -$2.38M 0.01% 419
2024
Q2 		$3.94M Buy
34,734
+12,319
+55% +$1.56M 0.07% 175
2024
Q1 		$3.11M Buy
22,415
+642
+3% +$80.7K 0.05% 216
2023
Q4 		$2.7M Buy
21,773
+20
+0.1% +$2.04K 0.05% 231
2023
Q3 		$2.03M Buy
21,753
+13,032
+149% +$1.47M 0.04% 249
2023
Q2 		$1.12M Sell
8,721
-300
-3% -$36.3K 0.02% 282
2023
Q1 		$1.05M Buy
+9,021
New +$1.01M 0.02% 303

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ABN AMRO Investment Solutions's DXCM Position: Q2 2026 in Review

ABN AMRO Investment Solutions increased its DexCom (DXCM) stake by 8.7% in Q2 2026, buying an estimated $232K and bringing the position to 43,326 shares worth $2.92M. The position accounts for 0.03% of the portfolio, ranked #339.

ABN AMRO Investment Solutions first reported a position in DXCM in Q1 2023 and has held it in 14 quarters since. The position peaked at $3.94M in Q2 2024. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • ABN AMRO Investment Solutions held 43,326 shares of DexCom worth $2.92M as of Q2 2026.
  • ABN AMRO Investment Solutions bought 3,475 DexCom shares in Q2 2026, an estimated $232K.
  • DexCom made up 0.03% of ABN AMRO Investment Solutions's portfolio in Q2 2026, its #339 holding.
  • ABN AMRO Investment Solutions first reported a position in DexCom in Q1 2023 and has held it in 14 quarters since.
  • ABN AMRO Investment Solutions's DexCom position peaked at $3.94M in Q2 2024.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on ABN AMRO Investment Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.